Coherus Oncology, Inc.
Clinical trials sponsored by Coherus Oncology, Inc., explained in plain language.
-
New cancer drug targets immune system in first human test
Disease control CompletedThis early-stage study tested the safety and initial effectiveness of a new drug called CHS-388 in adults with advanced solid tumors that had stopped responding to standard treatments. The drug, an antibody designed to target a specific immune system protein (IL-27), was tested b…
Phase: PHASE1 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for advanced liver cancer? trial tests adding a third drug to standard treatment
Disease control CompletedThis study tested whether adding a new drug called SRF388 to a standard two-drug treatment could better control advanced liver cancer. It involved about 134 adults with newly diagnosed, inoperable liver cancer who had not yet received treatment. The main goals were to see if the …
Phase: PHASE2 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC